for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Jianmin Pharmaceutical Group Co Ltd

600976.SS

Latest Trade

16.80CNY

Change

-0.22(-1.29%)

Volume

828,700

Today's Range

16.71

 - 

17.13

52 Week Range

13.69

 - 

20.68

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
17.02
Open
16.99
Volume
828,700
3M AVG Volume
30.52
Today's High
17.13
Today's Low
16.71
52 Week High
20.68
52 Week Low
13.69
Shares Out (MIL)
153.40
Market Cap (MIL)
2,610.84
Forward P/E
29.34
Dividend (Yield %)
1.18

Latest Developments

More

Jianmin Pharmaceutical Elects Wang Siyang As Chairman

Jianmin Pharmaceutical's Indirect Controlling Shareholder To Increase Shareholdings In The Company

Jianmin Pharmaceutical's Board Approves Appointment Of He Qin As Company President

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Jianmin Pharmaceutical Group Co Ltd

JIANMIN PHARMACEUTICAL GROUP CO., LTD., formerly Wuhan Jianmin Pharmaceutical Groups Co. Ltd, is a China-based company, principally engaged in the research and development, manufacture, wholesale and retailing of pharmaceuticals. The Company operates its businesses through two segments, including Pharmaceutical Industry and Pharmaceutical Business. The Pharmaceutical Industry segment is engaged in the research and development and manufacture of pharmaceuticals. Its products are mainly applied in children, women and the elderly, among others. The Pharmaceutical Business segment is engaged in the wholesale and retailing of pharmaceuticals. Its products include traditional Chinese medicine, Western medicine, health products, medical equipment and chemical agents. It distributes its products mainly in domestic market.

Industry

Major Drugs

Contact Info

No.484 Yingwu Avenue, Hanyang District

+86.27.84523350

http://www.whjm.com/

Executive Leadership

Qin He

Chairman of the Board

Qinqiang Liu

President, Director

Hongyun He

Chief Financial Officer

Zhenbo Hu

Vice President, Secretary of the Board

Fuliang Xiong

Vice President

Key Stats

1.50 mean rating - 2 analysts
Sell
Hold
Buy
EPS (CNY)

2016

0.420

2017

0.590

2018

0.530

2019(E)

0.580
Price To Earnings (TTM)
32.77
Price To Sales (TTM)
1.19
Price To Book (MRQ)
2.24
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
2.29
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
6.89
Return on Equity (TTM)
4.38

Latest News

BRIEF-Jianmin Pharmaceutical Group obtains high-tech enterprise recognition

* Says it will enjoy tax preference of 15 percent for three years from Nov. 28, 2017

BRIEF-Jianmin Pharmaceutical Group to sell 52.38 pct stake in Wuhan-based pharma unit

* Says it plans to sell entire 52.38 percent stake in a Wuhan-based pharma subsidiary to an individual for 11 million yuan

BRIEF-Jianmin Pharmaceutical Group to set up traditional Chinese medicine related unit in Wuhan

* Says it plans to invest 1 million yuan to set up a wholly owned traditional Chinese medicine related unit in Wuhan

BRIEF-Jianmin Pharmaceutical Group to invest 17.1 mln yuan in children's medicines research institute

* Says co plans to invest 17.1 million yuan in co's children's medicines research institute

BRIEF-Jianmin Pharmaceutical to invest 100 mln yuan to set up investment JV with partners

* Says it plans to invest 100 million yuan ($15.17 million) to set up investment JV with partners

BRIEF-Regulator halts review of Jianmin Pharmaceutical's share private placement

* Says securities regulator halts review of its share private placement proposal

BRIEF-Jianmin Pharmaceutical withdraws share private placement application from regulator

* Says it withdraws share private placement application from securities regulator

BRIEF-Jianmin Pharmaceutical Group to pay FY 2016 annual div on May 12

* Says it will pay cash dividend of 1 yuan per 10 shares (before tax) for every 10 shares to shareholders of record on May 11, for FY 2016

BRIEF-Jianmin Pharmaceutical Group to pay cash dividend of 1 yuan per 10 shares for 2016

* Says it will pay cash dividend of 1 yuan per 10 shares for 2016

BRIEF-Jianmin Pharmaceutical Group expects FY 2016 net profit to decrease by 15 to 30 pct

* Says net profit of FY 2016 expected to decrease by 15 percent to 30 percent

BRIEF-Jianmin Pharmaceutical Group to raise 1.14 bln yuan in private placement

* Says it plans to raise 1.14 billion yuan in private placement of shares

BRIEF-Jianmin Pharma plans to raise up to 1.14 bln yuan in share private placement to fund project

* Says it plans to raise up to 1.14 billion yuan ($170.94 million) in private placement of shares to fund project

BRIEF-Jianmin Pharmaceutical Group names chairman, president and CFO

* Says it names Liu Qinqiang as chairman of the board, Xu Sheng as president and Wang Shaoquan as CFO

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up